Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Massella

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Pediatric Nephrology (Berlin, Germany)|March 19, 2010
Cyclosporine A treatment in patients with Alport syndrome: a single-center experienceLaura Massella, Andrea Onetti Muda, Antonia Legato, et al.
European Journal of Pediatrics|December 15, 2010
Cobalamin C defect presenting as severe neonatal hyperammonemiaDiego Martinelli, Andrea Dotta, Laura Massella, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 25, 2009
Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndromeSeverin Kengne-Wafo, Laura Massella, Francesca Diomedi-Camassei, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 16, 2007
Lack of cardiac anomalies in children with NPHS2 mutationsGianluca Caridi, Monica Dagnino, Alba Carrea, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 2, 2013
Prognostic value of glomerular collagen IV immunofluorescence studies in male patients with X-linked Alport syndromeLaura Massella, Concetta Gangemi, Kostas Giannakakis, et al.
Frontiers in Immunology|January 5, 2026
Prolonged impairment of immunological memory after anti-CD20 treatment in pediatric idiopathic nephrotic syndrome: an extended follow-upManuela Colucci, Martina Riganati, Federica Zotta, et al.
Kidney International|March 20, 2018
Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working GroupClifford E Kashtan, Jie Ding, Guido Garosi, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|August 3, 2011
[TRPC6 mutations in children with steroid-resistant nephrotic syndrome]Maddalena Gigante, Gianluca Caridi, Eustacchio Montemurno, et al.
Journal of Cellular and Molecular Medicine|October 28, 2020
The carboxy-terminus of the human ARPKD protein fibrocystin can control STAT3 signalling by regulating SRC-activationClaudia Dafinger, Amrei M Mandel, Alina Braun, et al.
Frontiers in Pediatrics|November 19, 2021
Case Report: Two Cases of Pediatric Thrombotic Thrombocytopenic Purpura Treated With Combined TherapyCostanza Tripiciano, Paola Zangari, Mauro Montanari, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Pediatric Nephrology (Berlin, Germany)|March 19, 2010
Cyclosporine A treatment in patients with Alport syndrome: a single-center experienceLaura Massella, Andrea Onetti Muda, Antonia Legato, et al.
European Journal of Pediatrics|December 15, 2010
Cobalamin C defect presenting as severe neonatal hyperammonemiaDiego Martinelli, Andrea Dotta, Laura Massella, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 25, 2009
Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndromeSeverin Kengne-Wafo, Laura Massella, Francesca Diomedi-Camassei, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 16, 2007
Lack of cardiac anomalies in children with NPHS2 mutationsGianluca Caridi, Monica Dagnino, Alba Carrea, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 2, 2013
Prognostic value of glomerular collagen IV immunofluorescence studies in male patients with X-linked Alport syndromeLaura Massella, Concetta Gangemi, Kostas Giannakakis, et al.
Frontiers in Immunology|January 5, 2026
Prolonged impairment of immunological memory after anti-CD20 treatment in pediatric idiopathic nephrotic syndrome: an extended follow-upManuela Colucci, Martina Riganati, Federica Zotta, et al.
Kidney International|March 20, 2018
Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working GroupClifford E Kashtan, Jie Ding, Guido Garosi, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|August 3, 2011
[TRPC6 mutations in children with steroid-resistant nephrotic syndrome]Maddalena Gigante, Gianluca Caridi, Eustacchio Montemurno, et al.
Journal of Cellular and Molecular Medicine|October 28, 2020
The carboxy-terminus of the human ARPKD protein fibrocystin can control STAT3 signalling by regulating SRC-activationClaudia Dafinger, Amrei M Mandel, Alina Braun, et al.
Frontiers in Pediatrics|November 19, 2021
Case Report: Two Cases of Pediatric Thrombotic Thrombocytopenic Purpura Treated With Combined TherapyCostanza Tripiciano, Paola Zangari, Mauro Montanari, et al.
Pageof 6